Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 0.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 274,916 shares of the company’s stock after selling 714 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.22% of Henry Schein worth $19,024,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. FMR LLC increased its stake in shares of Henry Schein by 7.8% in the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after acquiring an additional 237,888 shares during the period. Southpoint Capital Advisors LP grew its position in Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after buying an additional 600,000 shares during the period. Nuance Investments LLC grew its position in Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after buying an additional 414,748 shares during the period. Clarkston Capital Partners LLC grew its position in Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after buying an additional 71,560 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in Henry Schein by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock valued at $85,662,000 after buying an additional 6,184 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $77.20 on Thursday. The company’s 50-day moving average price is $73.85 and its 200-day moving average price is $71.93. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $9.63 billion, a P/E ratio of 31.77, a P/E/G ratio of 2.21 and a beta of 0.91. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Wall Street Analysts Forecast Growth

Several analysts recently commented on HSIC shares. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Barrington Research raised their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Thursday, January 30th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and an average price target of $80.10.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.